Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Women's Health

Fitting Raloxifene Into the Hormone Replacement Puzzle

This month, Susan C. Stewart, M.D. discusses
CME credit is no longer available for this conference.

Course Authors

Susan C. Stewart, M.D.

Release Date: 06/24/1999

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Identify the effects of raloxifene on various tissues of the body

  • Discuss the adverse effects and contraindications to raloxifene

  • Determine which patients would derive the most benefit from raloxifene.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Sex-Related Differences in Addiction

While more men use and are addicted to drugs, women who become addicted progress faster through the landmark stages from initial use to dependence.
Authors: Jill B. Becker, Ph.D. and Jillian E. Hardee, Ph.D.
View Course
More

Caring for Women and Their Families: The Essential Role of Reproductive Rights

Medical professionals must manage reproductive rights in a highly politicized environment.
Authors: Nada L. Stotland, M.D., M.P.H.
View Course
More

Current and Emerging Therapies for Vulvo-vaginal Atrophy

Vulvo-vaginal atrophy in peri- and post-menopausal women is caused by declining, then deficient estrogen levels, and affects more than half of otherwise healthy women over age 60.
Authors: Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
View Course
More

Current Management of Endometriosis

Endometriosis remains one of the most complex pathologies faced by OBGYNs and primary care physicians.
Authors: Kenan Omurtag, M.D., and Amber R. Cooper, M.D., M.S.C.I.
View Course
More

Endometrial Cancer

Endometrial carcinoma is the most common female genital tract neoplasm in the United States.
Authors: Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.
View Course
More

Evaluation and Treatment of Polycystic Ovary Syndrome

Androgen Excess (AE)-PCOS Society recommended that PCOS be defined by clinical/biochemical hyperandrogenism.
Authors: Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.
View Course
More